In order to clarify the potential prognostic significance of PSME genes in patients with GC, we analyzed the relationship between expression levels of PSME genes and survival time of GC patients with different clinicopathological features, such as gender, Lauren classification, differentiation, HER2 status, and different kinds of treatment. The gene discussed is ERBB2; the disease is gastric cancer.